Crawford Ed
Impact in
-
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
Papers in
-
- Prostate Cancer Treatment and Research 11
- Prostate Cancer Diagnosis and Treatment 7
- Surgery 7
- Bladder and Urothelial Cancer Treatments 4
- Genital Health and Disease 2
- Co-authors
- Serdar Göktaş (2 shared papers)Ali Ziada (2 shared papers)Anibal Drelichman (1 shared paper)Von Hoff (1 shared paper)Fernand Labrie (1 shared paper)Ronald Lieberman (1 shared paper)Kelloff Gj (1 shared paper)John A. Sullivan (1 shared paper)
- Journals
- Prostate Cancer and Prostatic Diseases (4 papers)Urologic Oncology Seminars and Original Investigations (1 paper)PubMed (22 papers)
- Partner nations
- United StatesNetherlandsCanada
In The Last Decade
Crawford Ed
27 papers receiving 313 citations
Peers
Comparison fields: 5 of 64
- Pulmonary and Respiratory Medicine 175
- Urology 16
- Endocrinology, Diabetes and Metabolism 37
- Cancer Research 33
- Oncology 45
Countries citing papers authored by Crawford Ed
This map shows the geographic impact of Crawford Ed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Crawford Ed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Crawford Ed more than expected).
Fields of papers citing papers by Crawford Ed
This network shows the impact of papers produced by Crawford Ed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Crawford Ed. The network helps show where Crawford Ed may publish in the future.
Co-authors
The 22 scholars most cited alongside Crawford Ed, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Optimal hormonal therapy for advanced prostatic carcinoma. | 1999 | 60 |
| 2 | 1999 | 53 | |
| 3 | Adriamycin versus BCG in superficial bladder cancer: a Southwest Oncology Group Study. | 1989 | 31 |
| 4 | Mitoxantrone: modest activity in a phase II trial in advanced prostate cancer. | 1983 | 24 |
| 5 | Use of artificial neural networks in the clinical staging of prostate cancer: implications for prostate brachytherapy. | 2000 | 22 |
| 6 | 1999 | 21 | |
| 7 | The role of the urologist in treating patients with hormone-refractory prostate cancer. | 2003 | 16 |
| 8 | Southwest Oncology Group Study 8710: trial of cystectomy alone versus neo-adjuvant M-VAC and cystectomy in patients with locally advanced bladder cancer (Intergroup Trial 0080). | 1990 | 15 |
| 9 | Hormone therapy of advanced prostate cancer: where we stand today. | 1991 | 14 |
| 10 | Adrenal steroid levels in castrated men with prostatic carcinoma treated with aminoglutethimide plus hydrocortisone. | 1987 | 13 |
| 11 | Optimal timing of sipuleucel-T treatment in metastatic castration-resistant prostate cancer. | 2015 | 10 |
| 12 | 1997 | 8 | |
| 13 | Aminoglutethimide in metastatic adenocarcinoma of the prostate. | 1987 | 8 |
| 14 | National Cancer Institute study of luteinizing hormone-releasing hormone plus flutamide versus luteinizing hormone-releasing hormone plus placebo. | 1991 | 7 |
| 15 | Therapy for advanced renal cell cancer with spirogermanium: a Southwest Oncology Group Study. | 1987 | 6 |
| 16 | Radical ilioinguinal lymphadenectomy. | 1984 | 6 |
| 17 | 1998 | 4 | |
| 18 | Total androgen suppression: are there any advantages? The use of combined therapy in the treatment of advanced prostate adenocarcinoma. | 1988 | 4 |
| 19 | The Southwest Oncology Group Study for advanced testicular cancer. | 1984 | 2 |
| 20 | Advanced prostate cancer: therapeutic sequencing, outcomes, and cost implications. | 2012 | 2 |
About Crawford Ed
Crawford Ed is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Cancer Research, Oncology and Molecular Biology, having authored 27 papers that have together received 334 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (11 papers), Prostate Cancer Diagnosis and Treatment (7 papers), Bladder and Urothelial Cancer Treatments (4 papers), Hormonal and reproductive studies (3 papers), Cancer, Lipids, and Metabolism (3 papers), Urologic and reproductive health conditions (2 papers), Cancer Genomics and Diagnostics (2 papers) and Genital Health and Disease (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (175 citations), Urology (16 citations), Endocrinology, Diabetes and Metabolism (37 citations), Cancer Research (33 citations) and Oncology (45 citations). Crawford Ed has collaborated with scholars based in United States, Netherlands and Canada. Frequent co-authors include Serdar Göktaş, Ali Ziada, Anibal Drelichman, Von Hoff, Fernand Labrie, Ronald Lieberman, Kelloff Gj, John A. Sullivan, Thomas H. Stanisic and J. Montie. Their work appears in journals such as Prostate Cancer and Prostatic Diseases, Urologic Oncology Seminars and Original Investigations and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.